101 related articles for article (PubMed ID: 2687555)
1. [Serotonin and its physiological and pathophysiological roles. Ketanserin].
Metelitsa TV
Kardiologiia; 1989 Sep; 29(9):120-5. PubMed ID: 2687555
[No Abstract] [Full Text] [Related]
2. [The effect of pharmacologic blockade of serotonin receptors (S2) on arterial pressure in rats with 2 forms of hereditary arterial hypertension].
Popova NK; Piianzin AI; Markel' AL
Farmakol Toksikol; 1989; 52(6):58-61. PubMed ID: 2516487
[TBL] [Abstract][Full Text] [Related]
3. [Mechanism of action and use of antagonists of serotonin receptors S2, especially ketanserin, in the treatment of various diseases of the cardiovascular system].
Wiecek A; Grzeszczak W
Pol Tyg Lek; 1987 Mar; 42(10):304-8. PubMed ID: 3299308
[No Abstract] [Full Text] [Related]
4. [Clinical application of serotonin antagonists in the treatment of hypertension].
Deguchi F; Saito T; Inagaki Y
Nihon Rinsho; 1989 Sep; 47(9):2058-63. PubMed ID: 2593279
[No Abstract] [Full Text] [Related]
5. Platelet deactivation by 5HT2-receptor blockade parallels the antihypertensive response to ketanserin.
Amstein R; Fetkovska N; Pletscher A; Bühler FR
J Hypertens; 1989 Apr; 7(4):255-60. PubMed ID: 2723427
[TBL] [Abstract][Full Text] [Related]
6. Antihypertensive treatment with ketanserin shows no evidence of vascular serotonin2-receptor and alpha 1-adrenoceptor blockade.
Blauw GJ; Doorenbos CJ; Bruning TA; van Brummelen P; van Zwieten PA
Drugs; 1990; 40 Suppl 4():42-4. PubMed ID: 1982654
[No Abstract] [Full Text] [Related]
7. Antihypertensive effects of ketanserin and ritanserin in the spontaneously hypertensive rat.
Persson B; Gradin K; Pettersson A; Hedner T
J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S22-4. PubMed ID: 2459509
[TBL] [Abstract][Full Text] [Related]
8. Hemodynamic effects of the anti-hypertensive agent ketanserin in hypertension in man.
Weiss YA; Fournier V; Pannier B; Laurent S; Safar ME
Acta Cardiol; 1987; 42(5):329-37. PubMed ID: 3321806
[TBL] [Abstract][Full Text] [Related]
9. Serotonin agonists and antagonists in experimental hypertension.
Saxena PR; Bolt GR; Dhasmana KM
J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S12-8. PubMed ID: 2446059
[TBL] [Abstract][Full Text] [Related]
10. The rationale for ketanserin therapy in hypertension.
Hansson L; Hedner T
J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S39-44. PubMed ID: 2446068
[TBL] [Abstract][Full Text] [Related]
11. Serotoninergic mechanisms in hypertension. Focus on the effects of ketanserin.
Vanhoutte P; Amery A; Birkenhäger W; Breckenridge A; Bühler F; Distler A; Dormandy J; Doyle A; Frohlich E; Hansson L
Hypertension; 1988 Feb; 11(2):111-33. PubMed ID: 3277910
[TBL] [Abstract][Full Text] [Related]
12. [Effects of ketanserin on glucose metabolism in hypertensive diabetic subjects].
Carleo R; Gobbo M; Bonavita M; De Matteo A; Gallo M; Gatti A
Boll Soc Ital Biol Sper; 1990 Jul; 66(7):639-46. PubMed ID: 1964564
[TBL] [Abstract][Full Text] [Related]
13. [Role of serotonin in the regulation of the circulatory system].
Buczko W
Pol Tyg Lek; 1985 Apr; 40(16):469-72. PubMed ID: 3160011
[No Abstract] [Full Text] [Related]
14. Effect of intravenous ketanserin on arterial and intracranial pressures in patients with systemic hypertension following intracerebral haemorrhage.
Kay R; Poon WS; Nicholls MG
J Hum Hypertens; 1993 Aug; 7(4):369-71. PubMed ID: 8410928
[TBL] [Abstract][Full Text] [Related]
15. [Ketanserin. Lowering blood pressure using serotonin antagonists].
Uhl D
Med Monatsschr Pharm; 1989 Oct; 12(10):298-301. PubMed ID: 2811738
[No Abstract] [Full Text] [Related]
16. The use of ketanserin for postoperative hypertension after abdominal surgery.
Shu CC; Chan KH; Lee TY; Lui PW; Daiy YP; Ma JY; Chow LH
Ma Zui Xue Za Zhi; 1990 Dec; 28(4):465-70. PubMed ID: 2097488
[TBL] [Abstract][Full Text] [Related]
17. Ketanserin: a selective serotonin antagonist.
Lancet; 1982 Oct; 2(8303):859. PubMed ID: 6126719
[No Abstract] [Full Text] [Related]
18. [Role of serotonin and its receptors in the pathogenesis of arterial hypertension].
Belousov IuB; Krivonkin KIu
Kardiologiia; 1992; 32(11-12):5-9. PubMed ID: 1297881
[No Abstract] [Full Text] [Related]
19. Role of serotonin in the pathogenesis of acute and chronic pulmonary hypertension.
Egermayer P; Town GI; Peacock AJ
Thorax; 1999 Feb; 54(2):161-8. PubMed ID: 10325923
[No Abstract] [Full Text] [Related]
20. Serotonergic type-2 (5-HT2) antagonists: a novel class of cardiovascular drugs.
Robertson JI
J Cardiovasc Pharmacol; 1991; 17 Suppl 5():S48-53. PubMed ID: 1717773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
